Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis.
[There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis.]
Automated reference region extraction and population-based input function for brain [(11)C]TMSX PET image analyses.
MS susceptibility is not affected by single nucleotide polymorphisms in the MMP9 gene.
B cell VLA-4-deficiency reduces leukocyte recruitment and susceptibility to central nervous system autoimmunity.
Altered transition metal homeostasis in the cuprizone model of demyelination.
Anti-thyroid antibodies and cerebrospinal fluid findings in neuromyelitis optica spectrum disorders.
A microcontroller platform for the rapid prototyping of functional electrical stimulation-based gait neuroprostheses.
Visual Evoked Potential Recording in a Rat Model of Experimental Optic Nerve Demyelination.
Novel Therapeutic Targets and Drug Candidates for Modifying Disease Progression in Adrenoleukodystrophy.
Mortality in patients with multiple sclerosis.
Th1-mediated experimental autoimmune encephalomyelitis is CXCR3-independent.
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis.
Elevated levels of PPAR-gamma in the cerebrospinal fluid of patients with multiple sclerosis.
Relapsing optic neuritis: a multicentre study of 62 patients.
Consequences of perinatal bisphenol A exposure in a mouse model of multiple sclerosis.
Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy.
A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity.
Telehealth weight management intervention for adults with physical disabilities: a randomized controlled trial.
Grasping multiple sclerosis: do quantitative motor assessments provide a link between structure and function?
Immunization with a peptide of Semliki Forest virus promotes remyelination in experimental autoimmune encephalomyelitis.
Multiple sclerosis update.
Epstein-barr virus: the path from association to causality for a ubiquitous human pathogen.
Demyelinating disease: NMO spectrum disorders: clinical or molecular classification?
Health status and costs of ambulatory patients with multiple sclerosis in Hungary.
Pages
« first
‹ previous
…
464
465
466
467
468
469
470
471
472
…
next ›
last »